UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Texas Capital Bancshares Inc. TX

Texas Capital Bancshares Inc. TX reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the second quarter, HoldingsChannel.com reports. The firm owned 1,676 shares of the healthcare conglomerate’s stock after selling 36 shares during the period. Texas Capital Bancshares Inc. TX’s holdings in UnitedHealth Group were worth $806,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Bank Julius Baer & Co. Ltd Zurich lifted its stake in UnitedHealth Group by 97,436.9% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,029,274,230 shares of the healthcare conglomerate’s stock valued at $494,710,366,000 after purchasing an additional 1,028,218,963 shares during the last quarter. Moneta Group Investment Advisors LLC lifted its position in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Norges Bank acquired a new position in shares of UnitedHealth Group in the 4th quarter worth $5,210,004,000. Gateway Advisory LLC lifted its holdings in shares of UnitedHealth Group by 48,406.9% during the first quarter. Gateway Advisory LLC now owns 4,762,407 shares of the healthcare conglomerate’s stock valued at $4,762,000 after purchasing an additional 4,752,589 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in UnitedHealth Group by 264.2% in the 1st quarter. Envestnet Asset Management Inc. now owns 5,511,174 shares of the healthcare conglomerate’s stock worth $732,934,000 after purchasing an additional 3,997,959 shares in the last quarter. Institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $541.00 on Monday. The firm has a fifty day moving average price of $513.54 and a two-hundred day moving average price of $496.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.80 and a quick ratio of 0.80. The company has a market cap of $500.38 billion, a PE ratio of 23.49, a price-to-earnings-growth ratio of 1.64 and a beta of 0.63. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $553.00.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Friday, October 13th. The healthcare conglomerate reported $6.56 EPS for the quarter, topping analysts’ consensus estimates of $6.33 by $0.23. The company had revenue of $92.36 billion during the quarter, compared to the consensus estimate of $91.41 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.58%. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period last year, the firm earned $5.79 EPS. Analysts expect that UnitedHealth Group Incorporated will post 24.94 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, December 4th will be issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Friday, December 1st. UnitedHealth Group’s payout ratio is currently 32.64%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 121,515 shares of the business’s stock in a transaction dated Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total value of $65,688,578.70. Following the completion of the transaction, the director now directly owns 521,818 shares of the company’s stock, valued at $282,084,374.44. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $544.28, for a total value of $2,448,171.44. Following the transaction, the executive vice president now directly owns 9,218 shares in the company, valued at $5,017,173.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Stephen J. Hemsley sold 121,515 shares of the stock in a transaction on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total value of $65,688,578.70. Following the completion of the transaction, the director now directly owns 521,818 shares in the company, valued at approximately $282,084,374.44. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on UNH shares. Royal Bank of Canada boosted their price target on shares of UnitedHealth Group from $572.00 to $596.00 and gave the company an “outperform” rating in a report on Monday, October 16th. TD Cowen reduced their target price on UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating for the company in a report on Monday, July 17th. StockNews.com downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. Jefferies Financial Group upped their target price on UnitedHealth Group from $529.00 to $531.00 and gave the company a “hold” rating in a report on Monday, October 9th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on UnitedHealth Group from $564.00 to $555.00 in a research note on Monday, July 17th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $578.30.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.